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T
he prion protein (PrP) is a membrane-anchored, 
neuronal glycoprotein whose normal function is 
uncertain, but which plays a crucial role in prion 
diseases, a class of fatal neurodegenerative disorders of 
humans and animals [1]. Bovine spongiform encephalopathy 
(“mad cow disease”) and kuru, which are transmitted by 
eating contaminated tissues, are the best known examples of 
these disorders, which also occur in inherited and sporadic 
forms. In prion diseases, the normal, endogenous form of 
PrP (PrPC) undergoes transformation to a conformationally 
altered version (PrPSc) that accumulates in the brain 
as sticky, insoluble aggregates. This process leads to 
neuronal dysfunction and progressive neurodegeneration, 
for which there is no effective treatment. Unlike other 
neurodegenerative disorders like Alzheimer’s disease that 
are also due to protein misfolding, prion diseases are unique 
because they are transmissible. Prion propagation occurs by 
an unusual “protein-only” mechanism in which PrPSc imprints 
its aberrant conformation onto endogenous PrPCmolecules.
Similar protein-based transmission of biological information 
has been described in other organisms such as yeast and fungi 
[2], and may well turn out to be widespread in nature.
In the last two decades, an impressive number of studies has 
investigated nearly every aspect of the prion phenomenon. 
Nevertheless, we still have very little understanding of how 
PrPmisfolding causes neuronal dysfunction and death [3]. 
PrP knockout mice, in which the gene encoding PrP has 
been deleted, do not develop symptoms of prion disease, 
suggesting that pathogenesis may not be due simply to loss 
of an essential function of PrPC upon its conversion to PrPSc
[4–6]. Rather, it is commonly assumed that prion diseases 
result from a novel toxic activity acquired by PrPSc, analogous 
to the mechanism proposed for other dominantly inherited 
neurodegenerative disorders. Interestingly, neurons lacking 
endogenous, membrane-anchored PrPC seem to be resistant 
to the pathogenic effects of extracellular PrPSc [7–9]. This 
result suggests a connection between the neurotoxicity of 
PrPSc and the normal function of PrPC on the cell surface 
[10]. For example, when PrPC misfolds, its physiological 
activity might be altered as a consequence of oligomerization 
or abnormal interactions with partner proteins, resulting 
in generation of a toxic signal that is transmitted to the cell 
interior (Figure 1). Thus, ascertaining the normal function 
of PrPC and identifying its cellular interactors will be essential 
for understanding the molecular pathogenesis of prion 
diseases.
Approaches and Challenges To Unraveling PrP 
Function
Genetic ablation of PrP expression in mice, either prenatally 
or postnatally, produces relatively little phenotypic 
effect, other than an inability to propagate prions [11]. 
Although PrP knockout mice display no major anatomical 
or developmental defects, a bewildering variety of subtle 
abnormalities have been described in these mice (reviewed 
in [12]). These include altered circadian rhythms [13] 
and olfaction [14], abnormalities in neuronal transmission 
and electrical activity [15], defective proliferation 
and differentiation of neural precursor cells [16] and 
hematopoietic stem cells [17], increased sensitivity to 
hypoxia, ischemia, and seizures [18], and enhanced 
resistance to microbial infections [19]. Although intriguing, 
none of these reported abnormalities has provided a 
definitive clue to the normal function of PrPC.
Studies on the cell biology of PrPC have also failed to 
provide an unequivocal lead. Similar to other membrane 
glycoproteins, PrPC is synthesized in the rough endoplasmic 
reticulum, transits the Golgi, and is delivered to the cell 
surface, where it resides in lipid rafts [20]. Some PrPC
molecules are then transferred to clathrin-coated pits, from 
which they undergo endocytosis and recycling. The cellular 
localization of PrPC would be consistent with a number of 
different functions, including roles as a membrane receptor, 
adhesion molecule, or transporter. Perhaps the physiological 
activity that has emerged most frequently from a number of 
different cell culture studies is the ability of PrPC to provide 
protection against various kinds of cellular stress, including 
oxidative damage, that normally induce cell death [21]. This 
activity would be consistent with some of the phenotypes 
observed in PrP knockout mice, such as increased sensitivity 
to hypoxia and ischemia.
A powerful strategy for elucidating the physiological 
function of PrPC would be to identify other cellular proteins 
with which PrPC interacts. Several candidate binding partners 
of PrP have been identified using yeast two-hybrid or 
biochemical approaches, including low-density lipoprotein 
receptor-related protein 1, neural cell adhesion molecule, 
stress-inducible protein 1, laminin receptor precursor, Bcl-
2, and the potassium channel TREK-1 (reviewed in [21]). 
In most cases, however, the physiological relevance of the 
proposed interactions remains undocumented.
Recent studies demonstrate that selectively deleting 
certain sequence domains of PrP unleashes a powerful 
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neurotoxic signal, possibly as a result of alterations in 
the physiological activity normally performed by PrPC.
Transgenic mice expressing PrP molecules that lack portions 
of the unstructured N-terminus or central hydrophobic 
region display a dramatic neurodegenerative phenotype 
characterized by cerebellar degeneration and early death 
[22–24]. Amazingly, this phenotype is almost completely 
reverted by co-expression of full-length PrP, suggesting 
that the wild-type and deleted molecules interact in an 
antagonistic manner, either by complexing with each other 
or by competing for binding to a hypothetical membrane 
receptor. Working out the molecular details of these 
interactions will likely provide important insights into how 
PrPC controls neuronal death and survival.
In principle, the use of non-vertebrate model organisms 
that can be genetically manipulated would greatly facilitate 
functional analysis of PrP. However, the systems normally 
used, including the yeast Saccharomyces cerevisiae, the 
nematode Caenorhabditis elegans, or the fruit fly Drosophila
melanogaster, lack PrP homologous genes, precluding the 
possibility of carrying out a loss-of-function analysis. Attempts 
to model PrP-related phenotypes in these organisms by 
introducing heterologous PrP transgenes have generally been 
unrewarding, possibly because the required PrP-interacting 
proteins are not present. 
Recently, PrP-related genes have been identified in 
zebrafish, thereby bringing this model organism to the 
attention of prion researchers. The paper by Edward Málaga-
Trillo et al. in this issue of PLoS Biology [25] provides the 
first evidence for a strong PrP loss-of-function phenotype 
in a vertebrate system, offering potentially important new 
information on the physiological role of PrP.
A Glue Function for PrP
The tiny zebrafish Danio rerio has become a powerful tool 
for studying vertebrate development. Among the many 
advantages of this species is that it can be easily observed 
and manipulated experimentally. Zebrafish eggs are clear, 
and develop outside of the mother’s body, allowing scientists 
to watch them grow into a newly formed fish under a 
microscope. In addition, zebrafish are attractive from a 
genetic standpoint. Screens for mutant phenotypes are readily 
performed, and gene expression can be effectively knocked 
down, or exogenous genes expressed, by microinjecting the 
early embryo with antisense oligonucleotides or synthetic 
mRNAs, respectively. In addition, genetically modified 
cells can be transplanted into host embryos to analyze their 
behavior at different developmental stages, or to ask how 
mutant cells behave in wild-type embryos. Zebrafish have 
already been used successfully to model several human 
pathologies [26].
Because zebrafish are more closely related to humans than 
yeasts, nematodes, or fruit flies, they may be more useful 
for studying the function of a recently evolved protein like 
PrP. Like humans, zebrafish has its own PrP. In fact, two 
PrP-related genes, PrP-1 and PrP-2, have been identified 
that encode proteins sharing key structural features with 
mammalian PrP, including a signal peptide, a series of repeat 
sequences in the N-terminal region, a central hydrophobic 
domain, and a disulfide bond in the C-terminus [27,28]. The 
globular C-terminal domain is predicted to have the same 
arrangement of α-helices and β-strands as mammalian PrP. 
Moreover, zebrafish PrPs are glycosylated, and they contain a 
GPI anchor that attaches them to the cell surface [29].
What is the function of zebrafish PrP? To answer this 
question, Málaga-Trillo and colleagues began by studying 
the expression profile of the two genes, and found that PrP-
1 and -2 have complementary expression patterns during 
fish development. While PrP-1 transcripts are expressed 
ubiquitously and at high level in the early stages of 
embryogenesis, PrP-2 is up-regulated later in the developing 
nervous system, suggesting that the two genes may fulfill 
different roles in zebrafish life.
To test this prediction, the authors knocked down PrP-1
or -2 expression by microinjecting morpholino antisense 
oligonucleotides into embryos at the 1–4 cell stage. These 
embryos (morphants) exhibited a striking morphological 
phenotype. PrP-1 knockdown embryos failed to carry out 
gastrulation, revealing an essential role for PrP-1 in the early 
phase of the fish development. In contrast, PrP-2 knockdown 
embryos underwent normal gastrulation and survived 
until the early larval stage. However, the larvae displayed 
morphological defects in the head, specifically malformed 
brains and eyes, consistent with a role of the PrP-2 gene in 
neural differentiation and brain morphogenesis. The PrP-
1 morphant phenotype (gastrulation arrest) could be fully 
doi:10.1371/journal.pbio.1000075.g001
Figure 1. A Role for PrPC Function in Prion Diseases
PrPC on the cell surface performs its normal function by associating with a hypothetical transmembrane interactor (“X”). In the disease state, PrPSc (or a 
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rescued by microinjection of PrP-1 mRNA, and was partially 
suppressed by PrP-2 and mouse PrP mRNAs, suggesting 
functional conservation among all three PrP proteins.
But what is the functional activity of PrP whose absence 
produces such striking developmental abnormalities? To try 
and answer this question, the authors first investigated the 
cellular distribution of fish PrPs. By analyzing the localization 
of a series of PrP-EGFP (enhanced green fluorescent protein) 
chimeras in transfected mammalian cells and zebrafish 
embryos, they found that both PrP-1 and PrP-2 accumulated 
on the cell surface in regions of cell contact, with PrP-1 being 
restricted almost exclusively to these areas. Interestingly, 
mouse PrP was also concentrated at contact points. These 
observations led the authors to hypothesize that PrP-1 could 
play a role in cell–cell communication, a function that 
might be shared by mammalian PrP forms. Morphological 
examination of the PrP-1 morphant showed, in fact, that the 
developmental arrest was preceded by a marked decrease in 
tissue integrity, due to loss of embryonic cell adhesion.
A role for PrP-1 in cell adhesion was confirmed by the 
inability of embryonic cells lacking PrP-1 to form aggregates 
in culture. Moreover, embryonic cells from PrP-1 morphants 
could not establish normal cell contacts when grafted into 
wild-type embryos, indicating that the adhesion defect was 
cell autonomous, and could not be corrected by the normal 
cellular environment of the host embryos.
What is the molecular mechanism underlying the 
adhesion defects observed in these experiments? During 
gastrulation, cell adhesion is dynamically maintained by 
homophilic interactions of cadherins. Cadherins are a 
group of type-1 transmembrane proteins that play important 
roles in cell adhesion, ensuring that cells within tissues 
are bound together [30]. They are dependent on calcium 
ions to function; hence their name. While the cadherin 
extracellular domain is responsible for cell–cell interactions, 
the intracellular domain binds to the actin cytoskeleton via 
molecules known as catenins.
The authors found striking abnormalities of cadherin 
distribution in PrP-1 morphant embryos. E-cadherin (the 
cadherin isoform expressed in the early embryo) and 
β-catenin showed an abnormal intracellular distribution, 
and the actin cytoskeleton was disorganized. Biochemical 
investigation showed a reduction in the amount of the 
mature E-cadherin isoform (the one that is exposed on 
the cell surface), and an increase in the amount of the 
intracellular, immature form. In addition, the amount of 
E-cadherin colocalizing with a particular class of intracellular 
vesicles was significantly increased in PrP-1 morphants, 
indicating reduced E-cadherin trafficking to the plasma 
membrane. Thus, PrP-1 may modulate the function of 
E-cadherin by regulating its processing and/or transport to 
the cell surface.
The authors also showed that local accumulation of 
E-cadherin and β-catenin at newly formed cell contacts 
required PrP-1, and that this process was accompanied 
by accumulation of Fyn tyrosine kinase and tyrosine-
phosphorylated proteins at the contact points. These 
observations suggest that regulation of E-cadherin localization 
by PrP-1 may involve a signal transduction mechanism, 
including activation of Src-family tyrosine kinases.
In addition to demonstrating a role for PrP in regulating 
cadherin-mediated adhesion, Málaga-Trillo et al. also show 
that PrP has its own, intrinsic adhesive properties. Drosophila
Schneider 2 (S2) cells are normally non-adhesive, and grow 
in suspension as individual cells. However, if manipulated 
to express cell adhesion molecules, S2 cells can form 
multicellular aggregates. Since S2 cells do not express their 
own PrP, Málaga-Trillo et al. could directly test the effect of 
exogenous PrP expression on cell adhesion. This experiment 
showed that PrP expression promotes aggregation of S2 
cells, and that PrP accumulates at adhesive sites. Similar 
results were obtained when S2 cells were transfected with 
PrP from other species (frog, chicken, or mouse), suggesting 
that the propensity for homophilic interactions is a general 
property of PrP, and that cross-species interactions are also 
possible. In additional experiments, the authors showed that 
PrP-mediated adhesion was associated with tyrosine kinase-
based signal transduction events occurring within specialized 
domains of the plasma membrane. 
In summary, the study by Málaga-Trillo et al. indicates a 
role for zebrafish PrP-1 in modulating calcium-dependent cell 
adhesion in the developing fish embryo, through regulation 
of E-cadherin processing and/or trafficking (Figure 
2A). In addition, their work shows that PrP-1 itself, and 
possibly mammalian PrPs, can act as calcium-independent, 
homophilic adhesion molecules (Figure 2B).
Implications
The paper by Málaga-Trillo et al. is important for several 
reasons. First, it provides the first example of a dramatic 
phenotype caused by the absence of PrP. This is clearly 
different from the mild deficits described in PrP knockout 
mice. Second, the loss-of-function phenotype can be partially 
rescued by PrP from other species, including mammals, 
highlighting an evolutionarily conserved function for the 
protein. Third, the authors have shown that the knockdown 
phenotype is associated with a specific cellular deficit 
(abnormalities in cell adhesion), and in addition they have 
provided evidence that a transmembrane signaling function 
for PrP may play a role in the adhesion-promoting activities 
of the protein. Finally, this work is also important because 
it uses a simple animal model, which is amenable to genetic 
manipulation.
Clearly, much remains to be done to pursue these 
interesting observations. This study focuses primarily on the 
function of PrP-1, but it will be important now to analyze 
the role of PrP-2, which, based on its expression profile 
and morphant phenotype, is probably more closely related 
to mammalian PrP in terms of its physiological function 
in the brain. While there is evidence from this study that 
PrP-2 can partially substitute for PrP-1 in rescuing the 
morphant phenotype, it is possible that PrP-1 normally 
fulfills a specialized role in zebrafish that is not manifest in 
mammalian species, and that the two zebrafish PrP forms act 
in distinct cellular pathways or physiological processes. This 
may explain why fish express two PrP proteins, while higher 
vertebrates express only one. It is also worth noting that the 
peptide repeats in the N-terminus of zebrafish PrPs lack four 
conserved histidine residues that are responsible for copper 
binding in mammalian PrP [31], raising the possibility that 
fish PrP may lack some of the functional activities of PrP from 
higher species. Finally, it remains to be determined exactly 
how PrP-1 regulates E-cadherin trafficking. The authors 
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proteins, and instead suggest the involvement of signaling 
events triggered by PrP-1, for example tyrosine kinase 
activation induced by homophilic interactions between PrP-1 
molecules on adjacent cells.
Can the results of the Málaga-Trillo et al. study be 
related to any previous observations on PrP functionality in 
mammalian systems? The cell adhesion function of zebrafish 
PrP-1 is reminiscent of previous observations made in mouse 
neuroblastoma cells and hippocampal neurons, supporting a 
role for mammalian PrP in cell–cell interactions and neurite 
outgrowth [32–34]. In addition, some neurodevelopmental 
phenotypes have been described in PrP knockout mice 
[16,35], which could be related to those observed in zebrafish 
embryos. Finally, there is evidence that mammalian PrP is 
capable of activating protein kinase-based, transmembrane 
signaling cascades that may be similar to those described in 
this study [21].
Aside from demonstrating the importance of PrP-1 and 
PrP-2 in morphogenesis of the zebrafish embryo, the new 
results may also have implications for understanding prion 
diseases. Of course, prion diseases are not developmental 
disorders, and their associated neuropathology is distinct 
from the PrP morphant phenotypes observed in zebrafish. 
However, if PrPC plays a role in maintaining nerve cell 
contacts (synapses) in the adult brain, then loss of this 
function as a result of conversion to PrPSc could have 
deleterious effects that contribute to the disease state. 
Since some prion disorders are attributable to germline 
mutations in the PrP gene, it should be possible to test 
whether these pathogenic mutations cause a loss or gain 
of function phenotype in zebrafish. A fascinating question 
is whether zebrafish could be infected with prions. If so, 
then this organism could represent a powerful system for 
drug screening. Incidentally, fish for human consumption 
are sometimes fed with meat and bone meal [36], so the 
possibility of a “natural” prion infection in fish cannot be 
excluded. In conclusion, it seems likely that prion researchers 
will be hearing much more in the future from animals with 
fins as well as those with feet.  
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